Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 6, Issue 10, pp. 1174-1185
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 8, 2018
- Revision received May 20, 2018
- Accepted July 12, 2018
- Published first July 17, 2018.
Article Versions
- Previous version (July 17, 2018 - 06:47).
- Previous version (September 6, 2018 - 06:57).
- You are viewing the most recent version of this article.
Copyright & Usage
©2018 American Association for Cancer Research.
Author Information
- Sophie M. Poznanski1,
- Tina Nham1,
- Marianne V. Chew1,
- Amanda J. Lee1,
- Joanne A. Hammill1,
- Isabella Y. Fan1,
- Martin Butcher2,
- Jonathan L. Bramson1,
- Dean A. Lee3,
- Hal W. Hirte4, and
- Ali A. Ashkar1,*
- 1Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
- 2Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada.
- 3The Research Institute at Nationwide Children's Hospital, Ohio State University, Columbus, Ohio.
- 4Department of Oncology, Division of Medical Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.
- ↵*Corresponding Author:
Ali A. Ashkar, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada. Phone: 905-525-9140, ext. 22311; Fax: 905-522-6750; E-mail: ashkara{at}mcmaster.ca
October 2018
Volume 6, Issue 10
Volume 6, Issue 10
Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model
Jump to section
Advertisement